Neil S. Ryder

4.6k total citations · 1 hit paper
77 papers, 3.7k citations indexed

About

Neil S. Ryder is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Neil S. Ryder has authored 77 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 27 papers in Epidemiology and 17 papers in Pharmacology. Recurrent topics in Neil S. Ryder's work include Nail Diseases and Treatments (17 papers), Fungal Biology and Applications (14 papers) and Fungal Plant Pathogen Control (11 papers). Neil S. Ryder is often cited by papers focused on Nail Diseases and Treatments (17 papers), Fungal Biology and Applications (14 papers) and Fungal Plant Pathogen Control (11 papers). Neil S. Ryder collaborates with scholars based in Austria, United States and Switzerland. Neil S. Ryder's co-authors include Ingrid Leitner, Bertrand Favre, Marie-Claude Dupont, Anton Stütz, Gabor Petrányi, Mahmoud A. Ghannoum, Colin Osborne, N. Isham, Pranab K. Mukherjee and Steven D. Leidich and has published in prestigious journals such as Science, PLoS ONE and Biochemistry.

In The Last Decade

Neil S. Ryder

77 papers receiving 3.4k citations

Hit Papers

Allylamine Derivatives: New Class of Synthetic Antifungal... 1984 2026 1998 2012 1984 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil S. Ryder Austria 34 1.7k 1.3k 908 767 556 77 3.7k
G S Kobayashi United States 40 2.1k 1.2× 1.5k 1.2× 2.3k 2.5× 645 0.8× 274 0.5× 111 4.8k
Elias K. Manavathu United States 31 1.1k 0.6× 825 0.6× 1.6k 1.8× 247 0.3× 646 1.2× 89 3.2k
Masakazu Niimi Japan 31 1.7k 1.0× 1.1k 0.8× 2.3k 2.5× 218 0.3× 385 0.7× 88 3.4k
Yuzuru Mikami Japan 40 1.6k 0.9× 1.9k 1.5× 1.2k 1.3× 551 0.7× 1.6k 2.8× 265 6.5k
Peter E. Sudbery United Kingdom 31 1.5k 0.8× 2.9k 2.2× 2.4k 2.7× 575 0.7× 206 0.4× 59 4.8k
Maurizio Del Poeta United States 44 2.7k 1.5× 2.2k 1.6× 2.7k 3.0× 517 0.7× 581 1.0× 149 5.6k
Damian J. Krysan United States 37 1.8k 1.0× 1.8k 1.3× 2.5k 2.7× 402 0.5× 682 1.2× 120 4.9k
Dongmei Li United States 33 986 0.6× 1.1k 0.8× 1.4k 1.5× 275 0.4× 231 0.4× 137 2.9k
Piet W. J. de Groot Netherlands 34 1.5k 0.9× 2.2k 1.7× 2.3k 2.5× 401 0.5× 157 0.3× 74 4.6k
Rafael Sentandreu Spain 38 858 0.5× 2.5k 1.9× 1.7k 1.9× 338 0.4× 381 0.7× 158 4.4k

Countries citing papers authored by Neil S. Ryder

Since Specialization
Citations

This map shows the geographic impact of Neil S. Ryder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil S. Ryder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil S. Ryder more than expected).

Fields of papers citing papers by Neil S. Ryder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil S. Ryder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil S. Ryder. The network helps show where Neil S. Ryder may publish in the future.

Co-authorship network of co-authors of Neil S. Ryder

This figure shows the co-authorship network connecting the top 25 collaborators of Neil S. Ryder. A scholar is included among the top collaborators of Neil S. Ryder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil S. Ryder. Neil S. Ryder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richie, Daryl L., Katherine V. Thompson, Christian Studer, et al.. (2013). Identification and Evaluation of Novel Acetolactate Synthase Inhibitors as Antifungal Agents. Antimicrobial Agents and Chemotherapy. 57(5). 2272–2280. 35 indexed citations
2.
Tao, Jianshi, et al.. (2013). Involvement of Heat Shock Proteins in <b><i>Candida albicans</i></b> Biofilm Formation. Microbial Physiology. 23(6). 396–400. 26 indexed citations
3.
Davey, Rachel, et al.. (2010). Randomised controlled trial of additional lifestyle support for the reduction of cardiovascular disease risk through primary care in Stoke-on-Trent, UK. Contemporary Clinical Trials. 31(4). 345–354. 9 indexed citations
4.
Ryder, Neil S.. (2008). Discontinued drugs in 2007: anti-infectives. Expert Opinion on Investigational Drugs. 18(1). 1–11. 12 indexed citations
5.
Teo, Jeanette, Pamela Thayalan, David Beer, et al.. (2006). Peptide Deformylase Inhibitors as Potent Antimycobacterial Agents. Antimicrobial Agents and Chemotherapy. 50(11). 3665–3673. 47 indexed citations
7.
Molteni, Valentina, Andreas Kreusch, Perry Gordon, et al.. (2004). Identification of novel potent bicyclic peptide deformylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(6). 1477–1481. 32 indexed citations
8.
Seebàch, Dieter, Kenji Namoto, Yogesh R. Mahajan, et al.. (2004). Chemical and Biological Investigations of β‐Oligoarginines. Chemistry & Biodiversity. 1(1). 65–97. 65 indexed citations
9.
Favre, Bertrand, Mahmoud A. Ghannoum, & Neil S. Ryder. (2004). Biochemical characterization of terbinafine-resistantTrichophytonrubrumisolates. Medical Mycology. 42(6). 525–529. 38 indexed citations
10.
Jain, Rakesh, Sara López, Georg Neckermann, et al.. (2003). α-Substituted hydroxamic acids as novel bacterial deformylase inhibitor-based antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 13(23). 4223–4228. 26 indexed citations
11.
Behr, Jean‐Bernard, et al.. (2001). Inhibition of Chitin Synthetase fromSaccharomyces cerevisiaeby a New UDP-GlcNAc Analogue. Journal of enzyme inhibition. 16(2). 107–112. 10 indexed citations
12.
Ryder, Neil S. & Ingrid Leitner. (2001). Synergistic interaction of terbinafine with triazoles or amphotericin B againstAspergillusspecies. Medical Mycology. 39(1). 91–95. 103 indexed citations
13.
Behr, Jean‐Bernard, et al.. (2000). Synthesis of new (difluoromethylphosphono)azadisaccharides designed as bisubstrate analogue inhibitors for GlcNAc:β-1,4 glycosyltransferases. Bioorganic & Medicinal Chemistry Letters. 10(13). 1483–1486. 27 indexed citations
14.
Favre, Bertrand, et al.. (1999). Multiple amino acid substitutions in lanosterol 14α-demethylase contribute to azole resistance in Candida albicans. Microbiology. 145(10). 2715–2725. 76 indexed citations
15.
Ryder, Neil S., et al.. (1996). Characterization of prenyl protein transferase enzymes in a human keratinocyte cell line. Biochimica et Biophysica Acta (BBA) - General Subjects. 1289(1). 41–50. 4 indexed citations
16.
Ryder, Neil S., Harvinder Talwar, Nick J. Reynolds, John J. Voorhees, & Gary J. Fisher. (1993). Phosphatidic acid and phospholipase D both stimulate phosphoinositide turnover in cultured human keratinocytes. Cellular Signalling. 5(6). 787–794. 21 indexed citations
17.
Ryder, Neil S., et al.. (1992). Interaction of terbinafine with human serum and serum proteins. Medical Mycology. 30(6). 451–460. 29 indexed citations
18.
Ryder, Neil S.. (1992). Terbinafine: Mode of action and properties of the squalene epoxidase inhibition. British Journal of Dermatology. 126(s39). 2–7. 331 indexed citations
19.
Fisher, Gary J., Harvinder Talwar, Neil S. Ryder, & John J. Voorhees. (1989). Differential activation of human skin cells by platelet activating factor: Stimulation of phosphoinositide turnover and arachidonic acid mobilization in keratinocytes but not in fibroblasts. Biochemical and Biophysical Research Communications. 163(3). 1344–1350. 18 indexed citations
20.
Ryder, Neil S.. (1988). Mechanism of Action and Biochemical Selectivity of Allylamine Antimycotic Agents. Annals of the New York Academy of Sciences. 544(1). 208–220. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026